Holt Capital Partners’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.71M Buy
2,258
+306
+16% +$313K 0.32% 54
2026
Q1
$1.8M Buy
1,952
+222
+13% +$225K 0.24% 65
2025
Q4
$1.86M Buy
1,730
+20
+1% +$19.1K 0.25% 64
2025
Q3
$1.3M Buy
1,710
+20
+1% +$14.9K 0.21% 72
2025
Q2
$1.32M Hold
1,690
0.23% 69
2025
Q1
$1.4M Buy
1,690
+25
+2% +$20.8K 0.21% 74
2024
Q4
$1.29M Buy
1,665
+620
+59% +$513K 0.19% 78
2024
Q3
$926K Hold
1,045
0.14% 93
2024
Q2
$946K Buy
1,045
+625
+149% +$500K 0.2% 74
2024
Q1
$327K Sell
420
-625
-60% -$445K 0.05% 133
2023
Q4
$609K Buy
1,045
+645
+161% +$376K 0.11% 106
2023
Q3
$215K Sell
400
-656
-62% -$338K 0.04% 146
2023
Q2
$495K Buy
+1,056
New +$443K 0.09% 113
2023
Q1
Sell
-920
Closed -$337K 156
2022
Q4
$337K Buy
+920
New +$326K 0.07% 125
2022
Q3
Sell
-645
Closed -$209K 147
2022
Q2
$209K Buy
+645
New +$194K 0.04% 153
2016
Q2
Sell
-100
Closed -$7K 160
2016
Q1
$7K Buy
+100
New +$7.57K ﹤0.01% 217
2015
Q4
Sell
-100
Closed -$8K 156
2015
Q3
$8K Hold
100
﹤0.01% 225
2015
Q2
$8K Hold
100
﹤0.01% 229
2015
Q1
$7K Hold
100
﹤0.01% 231
2014
Q4
$7K Buy
+100
New +$6.75K ﹤0.01% 235

Other funds holding LLY

Holt Capital Partners's LLY Position: Q2 2026 in Review

Holt Capital Partners increased its Eli Lilly (LLY) stake by 16% in Q2 2026, buying an estimated $313K and bringing the position to 2,258 shares worth $2.71M. The position accounts for 0.32% of the portfolio, ranked #54.

Holt Capital Partners first reported a position in LLY in Q4 2014 and has held it in 20 quarters since. 4,618 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Holt Capital Partners held 2,258 shares of Eli Lilly worth $2.71M as of Q2 2026.
  • Holt Capital Partners bought 306 Eli Lilly shares in Q2 2026, an estimated $313K.
  • Eli Lilly made up 0.32% of Holt Capital Partners's portfolio in Q2 2026, its #54 holding.
  • Holt Capital Partners first reported a position in Eli Lilly in Q4 2014 and has held it in 20 quarters since.
  • 4,618 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Holt Capital Partners's 13F filing for Q2 2026, filed 14 Aug 2026.